Outcomes Study: Identifying Barriers to Treatment with Psychiatric Medications Among People Who Are Incarcerated

All Posts

Outcomes Study: Identifying Barriers to Treatment with Psychiatric Medications Among People Who Are Incarcerated

Background

  • 9-20% of the 2.3 million people in U.S. jails and prisons have a serious mental illness
  • Wilper et al. found that 26.3% of federal inmates, 28.9% of state inmates, and 41.8% of jail inmates were not continued on home medications while incarcerated
  • Lack of access to mental health medications can lead to decompensation, disciplinary action from correctional staff, increased victimization from other inmates, and placement in solitary confinement
  • Lack of access can also result in admission to state mental health facilities to restore competency which requires continued medication access upon return to jail
  • Studies have noted that jails often lack resources for appropriate medication management, psychosocial assessments, and crisis intervention
  • While there have been studies on resources and treatment barriers for inmates, there is a lack of information focused specifically on medications

Objectives

Primary Objective

Characterize the barriers to receiving psychiatric medications for people who are incarcerated

Secondary Objectives

  • Compare the barriers to receiving psychiatric medications for people who are incarcerated before competency restoration to after competency restoration
  • Characterize psychiatric medication formularies of jails

 

Read the Outcomes Study by submitting the form below.

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.